FDA recall D-0400-2026 · initiated Mar 9, 2026
May cause temporary or medically reversible harm; low probability of serious harm.
Failed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.